- call +1-201-465-4211
- email sales@mrinsights.biz
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.
Scope of the Report:
This report focuses on the Orphan Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
High unmet needs are one of the primary drivers of market growth. The need for the development of effective drugs with lesser side-effects is rapidly rising in the market.
Moreover, the initiatives from the governments of various countries across the globe towards R&D activities and numerous marketing approvals of these drugs have also influenced the orphan drugs market growth. Furthermore, the rising occurrences of rare diseases with the mounting awareness among the population and larger life expectancy numbers have accelerated the global orphan drug market to grow higher.
The worldwide market for Orphan Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Novartis
Bristol-Myers Squibb
Celgene
Roche
Pfizer
Sanofi
Alexion Pharmaceuticals
Eli Lilly
Novo Nordisk
AstraZeneca
Eisai
Daiichi Sankyo
Bayer
GlaxoSmithKline
Merck
Johnson & Johnson
Biogen
Shire
Amgen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
There are 15 Chapters to deeply display the global Orphan Drugs market.
Chapter 1, to describe Orphan Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Orphan Drugs, with sales, revenue, and price of Orphan Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Orphan Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Orphan Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Orphan Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Orphan Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Oncology
1.2.2 Gastrointestinal
1.2.3 Pulmonary
1.2.4 Neurology
1.2.5 Hematology
1.2.6 Cardio-vascular
1.2.7 Metabolic disorders
1.2.8 Endocrinology
1.2.9 Infectious diseases
1.2.10 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Speciality Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Orphan Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Orphan Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
2.3.1 Business Overview
2.3.2 Orphan Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celgene Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche
2.4.1 Business Overview
2.4.2 Orphan Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Orphan Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Orphan Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Alexion Pharmaceuticals
2.7.1 Business Overview
2.7.2 Orphan Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Alexion Pharmaceuticals Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eli Lilly
2.8.1 Business Overview
2.8.2 Orphan Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Novo Nordisk
2.9.1 Business Overview
2.9.2 Orphan Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novo Nordisk Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Orphan Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Eisai
2.11.1 Business Overview
2.11.2 Orphan Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eisai Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Daiichi Sankyo
2.12.1 Business Overview
2.12.2 Orphan Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Daiichi Sankyo Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Bayer
2.13.1 Business Overview
2.13.2 Orphan Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bayer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 GlaxoSmithKline
2.14.1 Business Overview
2.14.2 Orphan Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 GlaxoSmithKline Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Merck
2.15.1 Business Overview
2.15.2 Orphan Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Merck Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Johnson & Johnson
2.16.1 Business Overview
2.16.2 Orphan Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Johnson & Johnson Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Biogen
2.17.1 Business Overview
2.17.2 Orphan Drugs Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Biogen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Shire
2.18.1 Business Overview
2.18.2 Orphan Drugs Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Shire Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Amgen
2.19.1 Business Overview
2.19.2 Orphan Drugs Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Amgen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Orphan Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Orphan Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Orphan Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Orphan Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Orphan Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Orphan Drugs Market Analysis by Regions
4.1 Global Orphan Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Orphan Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Orphan Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Orphan Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Orphan Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Orphan Drugs Sales and Growth Rate (2013-2018)
4.5 South America Orphan Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Orphan Drugs Sales and Growth Rate (2013-2018)
5 North America Orphan Drugs by Countries
5.1 North America Orphan Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Orphan Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Orphan Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Orphan Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Orphan Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Orphan Drugs Sales and Growth Rate (2013-2018)
6 Europe Orphan Drugs by Countries
6.1 Europe Orphan Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Orphan Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Orphan Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Orphan Drugs Sales and Growth Rate (2013-2018)
6.3 UK Orphan Drugs Sales and Growth Rate (2013-2018)
6.4 France Orphan Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Orphan Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Orphan Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Orphan Drugs by Countries
7.1 Asia-Pacific Orphan Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Orphan Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Orphan Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Orphan Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Orphan Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Orphan Drugs Sales and Growth Rate (2013-2018)
7.5 India Orphan Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Orphan Drugs Sales and Growth Rate (2013-2018)
8 South America Orphan Drugs by Countries
8.1 South America Orphan Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Orphan Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Orphan Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Orphan Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Orphan Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Orphan Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Orphan Drugs by Countries
9.1 Middle East and Africa Orphan Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Orphan Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Orphan Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Orphan Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Orphan Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Orphan Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Orphan Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Orphan Drugs Sales and Growth Rate (2013-2018)
10 Global Orphan Drugs Market Segment by Type
10.1 Global Orphan Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Orphan Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Orphan Drugs Revenue and Market Share by Type (2013-2018)
10.2 Oncology Sales Growth and Price
10.2.1 Global Oncology Sales Growth (2013-2018)
10.2.2 Global Oncology Price (2013-2018)
10.3 Gastrointestinal Sales Growth and Price
10.3.1 Global Gastrointestinal Sales Growth (2013-2018)
10.3.2 Global Gastrointestinal Price (2013-2018)
10.4 Pulmonary Sales Growth and Price
10.4.1 Global Pulmonary Sales Growth (2013-2018)
10.4.2 Global Pulmonary Price (2013-2018)
10.5 Neurology Sales Growth and Price
10.5.1 Global Neurology Sales Growth (2013-2018)
10.5.2 Global Neurology Price (2013-2018)
10.6 Hematology Sales Growth and Price
10.6.1 Global Hematology Sales Growth (2013-2018)
10.6.2 Global Hematology Price (2013-2018)
10.7 Cardio-vascular Sales Growth and Price
10.7.1 Global Cardio-vascular Sales Growth (2013-2018)
10.7.2 Global Cardio-vascular Price (2013-2018)
10.8 Metabolic disorders Sales Growth and Price
10.8.1 Global Metabolic disorders Sales Growth (2013-2018)
10.8.2 Global Metabolic disorders Price (2013-2018)
10.9 Endocrinology Sales Growth and Price
10.9.1 Global Endocrinology Sales Growth (2013-2018)
10.9.2 Global Endocrinology Price (2013-2018)
10.10 Infectious diseases Sales Growth and Price
10.10.1 Global Infectious diseases Sales Growth (2013-2018)
10.10.2 Global Infectious diseases Price (2013-2018)
10.11 Others Sales Growth and Price
10.11.1 Global Others Sales Growth (2013-2018)
10.11.2 Global Others Price (2013-2018)
11 Global Orphan Drugs Market Segment by Application
11.1 Global Orphan Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacies Sales Growth (2013-2018)
11.3 Speciality Pharmacies Sales Growth (2013-2018)
11.4 Retail pharmacies Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Orphan Drugs Market Forecast (2018-2023)
12.1 Global Orphan Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Orphan Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Orphan Drugs Market Forecast (2018-2023)
12.2.2 Europe Orphan Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Orphan Drugs Market Forecast (2018-2023)
12.2.4 South America Orphan Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Orphan Drugs Market Forecast (2018-2023)
12.3 Orphan Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Orphan Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Orphan Drugs Market Share Forecast by Type (2018-2023)
12.4 Orphan Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Orphan Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Orphan Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Orphan Drugs Picture
Table Product Specifications of Orphan Drugs
Figure Global Sales Market Share of Orphan Drugs by Types in 2017
Table Orphan Drugs T
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
